Trends in Prescription Drug Launch Prices, 2008-2021

This study uses SSR Health data on drug list prices and estimated net prices after manufacturer discounts to evaluate trends in prices for newly marketed brand-name prescription drugs in the US from 2008 to 2021.

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2022-06, Vol.327 (21), p.2145-2147
Main Authors: Rome, Benjamin N, Egilman, Alexander C, Kesselheim, Aaron S
Format: Article
Language:English
Subjects:
Drug Costs - trends
Drug Industry - economics
Drug Industry - trends
Drugs, Generic
Health Services Accessibility
Humans
Letter
Letters
Prescription Drugs - economics
Research Letter
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study uses SSR Health data on drug list prices and estimated net prices after manufacturer discounts to evaluate trends in prices for newly marketed brand-name prescription drugs in the US from 2008 to 2021.
ISSN:0098-7484
1538-3598
1538-3598
DOI:10.1001/jama.2022.5542